JP2011525479A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525479A5
JP2011525479A5 JP2011511735A JP2011511735A JP2011525479A5 JP 2011525479 A5 JP2011525479 A5 JP 2011525479A5 JP 2011511735 A JP2011511735 A JP 2011511735A JP 2011511735 A JP2011511735 A JP 2011511735A JP 2011525479 A5 JP2011525479 A5 JP 2011525479A5
Authority
JP
Japan
Prior art keywords
nsaids
composition
antihypertensive agents
diuretic
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011511735A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525479A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/044966 external-priority patent/WO2009154944A2/en
Publication of JP2011525479A publication Critical patent/JP2011525479A/ja
Publication of JP2011525479A5 publication Critical patent/JP2011525479A5/ja
Pending legal-status Critical Current

Links

JP2011511735A 2008-05-28 2009-05-22 非ステロイド性抗炎症性化合物と降圧化合物とを組み合わせた製剤処方及びその使用方法 Pending JP2011525479A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5678908P 2008-05-28 2008-05-28
US61/056,789 2008-05-28
US9797208P 2008-09-18 2008-09-18
US61/097,972 2008-09-18
PCT/US2009/044966 WO2009154944A2 (en) 2008-05-28 2009-05-22 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds

Publications (2)

Publication Number Publication Date
JP2011525479A JP2011525479A (ja) 2011-09-22
JP2011525479A5 true JP2011525479A5 (https=) 2012-07-05

Family

ID=41434626

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011511735A Pending JP2011525479A (ja) 2008-05-28 2009-05-22 非ステロイド性抗炎症性化合物と降圧化合物とを組み合わせた製剤処方及びその使用方法

Country Status (7)

Country Link
US (2) US20110207724A1 (https=)
EP (1) EP2285371A4 (https=)
JP (1) JP2011525479A (https=)
AU (1) AU2009260632A1 (https=)
CA (1) CA2726337A1 (https=)
MX (1) MX2010012836A (https=)
WO (1) WO2009154944A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015191460A1 (en) * 2014-06-08 2015-12-17 Autotelic Llc Fixed dose combination for pain relief without edema
WO2019067768A2 (en) * 2017-09-28 2019-04-04 Nevakar, Inc. FIXED DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN
WO2020091711A1 (en) * 2018-11-01 2020-05-07 Pisak Mehmet Nevzat Pharmaceutical combinations for the treatment of pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155120A (en) * 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
US20040186155A1 (en) * 2003-01-30 2004-09-23 Dayno Jeffrey Marc Combination therapy for the treatment or prevention of migraine
WO2006102476A2 (en) * 2005-03-21 2006-09-28 Vicus Therapeutics Spe 1, Llc Compositions and methods for ameliorating cachexia
US20070037797A1 (en) * 2005-08-15 2007-02-15 Hellstrom Harold R Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events

Similar Documents

Publication Publication Date Title
IL194885A0 (en) Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
WO2007078874A3 (en) Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
WO2011079239A3 (en) Combination tablet with chewable outer layer
NO20085302L (no) Farmasoytisk preparat omfattende Amlodipin og Losartan
WO2007112274A3 (en) Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
JP2015508082A5 (https=)
JP2018513171A5 (https=)
WO2008011426A3 (en) Methods and medicaments for administration of ibuprofen
CL2007002921A1 (es) Forma solida de dosificacion farmaceutica de administracion oral, que comprende una forma cristalina o amorfa de un compuesto microincluido en un polimero ionico insoluble en agua en proporcion 5:1 a 1:5; y metodo de preparacion.
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
EA201291247A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ В ФОРМЕ ДВУХСЛОЙНЫХ ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР HMG-CoA РЕДУКТАЗЫ И ИРБЕСАРТАН
NZ602029A (en) Use of meloxicam for the long-term treatment of kidney disorders in cats
HRP20171743T1 (hr) Sastavi i postupci za savladavanje otpornosti na tramadol
JP2009504774A5 (https=)
JP2009517411A5 (https=)
WO2008106689A3 (en) Breakthrough pain management
JP2011525479A5 (https=)
JP2012527438A5 (https=)
JP2015522658A5 (https=)
TR200708925A1 (tr) Kontrollü salım sağlayan flurbiprofen ve kas gevşetici kombinasyonları
WO2009154944A3 (en) Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds
RU2015112586A (ru) Фармацевтические композиции, содержащие флурбипрофен
RU2017113827A (ru) Фармацевтический состав для уменьшения спазмов мочевого пузыря и способ его применения
Day Another selective COX-2 inhibitor: more questions than answers?